Z4D.SI Medi Lifestyle (SES) pre-market top gainer 31 Jan 2026: eye S$0.02 upside
Z4D.SI stock trades in the Singapore pre-market at S$0.012, marking it among the session’s top gainers on 31 Jan 2026. Trading volume is light at 25,000 shares versus an average of 922,566, which amplifies intraday moves. The stock sits between a year low S$0.006 and year high S$0.016, and recent three‑month returns are strong at +40.00%. We profile price drivers, valuation, technicals, and Meyka AI’s forward view to explain why traders are watching this Healthcare name on the SES.
Z4D.SI stock quick snapshot and market context
Medi Lifestyle Limited (Z4D.SI) is listed on the SES in Singapore and trades at S$0.012 with a market cap of about S$2,251,234. The company’s business covers postpartum care, alternative medicine and commodity trading under brands like NADORA and Back to Life. Short term averages show a 50‑day price near S$0.011 and a 200‑day price near S$0.009, suggesting recent strength versus longer trend.
Z4D.SI stock drivers: why the pre-market gain appears
The immediate driver is sector momentum in Healthcare, which shows a 3M gain of +10.27% and supports small cap rallies. Z4D.SI’s own 3‑month performance rose +40.00%, likely reflecting renewed interest in its postpartum and outsourced services. Low float dynamics and thin trading—volume 25,000 versus average 922,566—can magnify moves when buyers reappear.
Z4D.SI stock financials and valuation snapshot
Medi Lifestyle reports negative earnings with EPS -0.01 and a distorted PE -1.40, signaling losses and caution for valuation models. Price to sales is near 1.30, current ratio 0.52, and book value per share is negative at roughly -0.014. These metrics indicate tight liquidity and elevated operational risk despite modest revenue per share of 0.033.
Z4D.SI stock technicals and trading setup
Momentum indicators show an RSI of 63.70 and ADX 42.80, indicating a strong short‑term trend but not runaway strength. Money flow looks hot with MFI 93.98, which flags overbought conditions and potential pullbacks. Price averages slope higher and on‑balance volume reads 27,023,100, suggesting accumulation during prior moves.
Z4D.SI stock Meyka grade and model forecast
Meyka AI rates Z4D.SI with a score out of 100: 62.73 | Grade B | Suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month target S$0.04732, implying an upside of +294.36% from the current S$0.012; forecasts are model‑based projections and not guarantees.
Z4D.SI stock risks, targets and sector view
Key risks include negative operating margins, weak current ratio, and concentrated trading volume that can swing price quickly. Our near‑term price target is S$0.02, a 67% rise from today and aligned with the monthly forecast. A 12‑month base target is S$0.047 and a three‑year scenario target is S$0.115, reflecting model scenarios and sector tailwinds in Singapore Healthcare.
Final Thoughts
Z4D.SI stock is a pre-market top gainer on 31 Jan 2026 trading at S$0.012, driven by Healthcare sector momentum and thin liquidity that amplifies moves. Valuation remains challenging with EPS -0.01, PE -1.40, and a negative book value, so fundamental investors face material downside risk. Technicals show a strong trend with RSI 63.70 and ADX 42.80, but MFI 93.98 warns of an overbought short term. Meyka AI’s forecast model projects S$0.04732 in 12 months, implying +294.36% upside from current levels, yet this projection is model‑based and not a guarantee. Traders should treat Z4D.SI as a high‑volatility speculative position on the SES, size positions carefully, and monitor upcoming earnings and liquidity changes. For company context see the official site Medi Lifestyle and the company profile image Company Profile. Meyka AI provided this data as an AI‑powered market analysis platform.
FAQs
What is the current price and trading status of Z4D.SI stock?
Z4D.SI stock trades pre‑market at S$0.012 on the SES with volume 25,000 shares and an average volume of 922,566; liquidity is thin and price moves can be amplified.
What valuation metrics matter for Z4D.SI stock?
Key metrics include EPS -0.01, PE -1.40, price‑to‑sales ~1.30, and current ratio 0.52; these signal negative earnings and constrained short‑term liquidity.
What targets does Meyka AI give for Z4D.SI stock?
Meyka AI’s model projects a 12‑month target of S$0.04732 and a near‑term level of S$0.02; forecasts are model outputs and not guaranteed outcomes.
Should investors treat Z4D.SI stock as high risk?
Yes. Z4D.SI stock shows negative margins, low current ratio, and thin trading, which make it a high‑risk, high‑volatility candidate suitable only for speculative allocations.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
